The stock of CRISPR Therapeutics AG (CRSP) has gone down by -1.95% for the week, with a 11.05% rise in the past month and a
The stock price of CRISPR Therapeutics AG (NASDAQ: CRSP) has surged by 3.73 when compared to previous closing price of 37.82, but the company has
The 36-month beta value for CRSP is at 1.82. Analysts have varying views on the stock, with 12 analysts rating it as a “buy,” 5
Additionally, the 36-month beta value for CRSP is 1.78. There are mixed opinions on the stock, with 12 analysts rating it as a “buy,” 5
CRSP has 36-month beta value of 1.81. Analysts have mixed views on the stock, with 12 analysts rating it as a “buy,” 5 as “overweight,”
CRISPR Therapeutics AG (NASDAQ: CRSP) has seen a decline in its stock price by -4.06 in relation to its previous close of 42.62. However, the
The stock of CRISPR Therapeutics AG (CRSP) has gone down by -3.94% for the week, with a -18.14% drop in the past month and a
© 2024, Powered by Smart TechOne
